Cargando…

Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil

Chagas disease (CD) is a neglected tropical disease that affects individuals in almost every country in Latin America. There are two available drugs with antiparasitic profiles; however, only benznidazole (BZN) has been approved for commercialization in Brazil. The usefulness of prescribing BZN for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferreira, Ariela Mota, Sabino, Ester Cerdeira, de Oliveira, Lea Campos, Oliveira, Cláudia Di Lorenzo, Cardoso, Clareci Silva, Ribeiro, Antônio Luiz Pinho, Haikal, Desirée Sant’Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5113907/ https://www.ncbi.nlm.nih.gov/pubmed/27855177 http://dx.doi.org/10.1371/journal.pone.0165950

Ejemplares similares

Failure to use health services by people with Chagas disease: Multilevel analysis of endemic area in Brazil
por: Damasceno, Renata Fiúza, et al.
Publicado: (2022)

Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile
por: Cardoso, Clareci Silva, et al.
Publicado: (2016)

Evaluation of the properties of WHODAS-12 measurements in individuals with Chagas disease in Brazil
por: Tavares, Patrícia Aparecida, et al.
Publicado: (2023)

Serological screening for Chagas disease in an endemic region of Northern Minas Gerais, Brazil: the SaMi-Trop project
por: Cruz, Dardiane Santos, et al.
Publicado: (2021)

Impact of the social context on the prognosis of Chagas disease patients: Multilevel analysis of a Brazilian cohort
por: Ferreira, Ariela Mota, et al.
Publicado: (2020)

Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study
por: Cardoso, Clareci Silva, et al.
Publicado: (2018)

Risk Score for Predicting 2‐Year Mortality in Patients With Chagas Cardiomyopathy From Endemic Areas: SaMi‐Trop Cohort Study
por: Di Lorenzo Oliveira, Claudia, et al.
Publicado: (2020)

Contextual influence on poor self-rated health in patients with Chagas disease: multilevel study
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Hospitalizations due to gastrointestinal Chagas disease: National registry
por: Bierrenbach, Ana Luiza, et al.
Publicado: (2022)

Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study
por: Martins Barros, Isabella Morais, et al.
Publicado: (2021)

Cohort profile update: the main and new findings from the SaMi-Trop Chagas cohort
por: Oliveira, Claudia Di Lorenzo, et al.
Publicado: (2021)

Lack of evidence of seronegative infection in an endemic area of Chagas disease
por: de Oliveira, Léa Campos, et al.
Publicado: (2019)

Overview of Chagas disease surveillance in an endemic region in Southeastern Brazil
por: Rafael, Aline Ferreira, et al.
Publicado: (2023)

Chagas disease and perceived quality of life: a cross-sectional study
por: Baldoni, Nayara Ragi, et al.
Publicado: (2023)

Two-year death prediction models among patients with Chagas Disease using machine learning-based methods
por: Ferreira, Ariela Mota, et al.
Publicado: (2022)

Factors associated with quality of life in patients with Chagas disease: SaMi-Trop project
por: Quintino, Nayara Dornela, et al.
Publicado: (2020)

Population pharmacokinetic modeling of benznidazole in Brazilian patients with chronic Chagas disease
por: Frade, Virgínia Paula, et al.
Publicado: (2022)

Challenges in the care of patients with Chagas disease in the Brazilian public health system: A qualitative study with primary health care doctors
por: Damasceno, Renata Fiúza, et al.
Publicado: (2020)

Anti-Trypanosoma cruzi antibody profiling in patients with Chagas disease treated with benznidazole assessed by genome phage display
por: Rodriguez Carnero, Luis Antonio, et al.
Publicado: (2023)

Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature
por: Sabino, Ester Cerdeira, et al.
Publicado: (2022)

Quality of life in patients with Chagas disease and the instrument used: an integrative review
por: Baldoni, Nayara Ragi, et al.
Publicado: (2021)

Left ventricular systolic dysfunction predicted by artificial intelligence using the electrocardiogram in Chagas disease patients–The SaMi-Trop cohort
por: Brito, Bruno Oliveira de Figueiredo, et al.
Publicado: (2021)

Rare Pathogenic Variants in Mitochondrial and Inflammation-Associated Genes May Lead to Inflammatory Cardiomyopathy in Chagas Disease
por: Ouarhache, Maryem, et al.
Publicado: (2021)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
por: Gontijo, Maria Katarine Costa Lucas, et al.
Publicado: (2020)

Screening for Chagas disease from the electrocardiogram using a deep neural network
por: Jidling, Carl, et al.
Publicado: (2023)

From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease
por: Gomes, Daniele Cavalcante, et al.
Publicado: (2023)

Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole
por: Franco, Lucas A. M., et al.
Publicado: (2021)

Benznidazole, itraconazole and their combination in the treatment of acute experimental Chagas disease in dogs
por: Cunha, Eleonora Lima Alves, et al.
Publicado: (2019)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease
por: de Oliveira-Silva, Jaquelline Carla Valamiel, et al.
Publicado: (2015)

Benznidazole as Prophylaxis for Chagas Disease Infection Reactivation in Heart Transplant Patients: A Case Series in Brazil
por: Rossi Neto, Joao Manoel, et al.
Publicado: (2020)

Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
por: Diniz, Lívia de Figueiredo, et al.
Publicado: (2013)

Mapping the morbidity and mortality of Chagas disease in an endemic area in Brazil
por: Medeiros, Carolina de Araújo, et al.
Publicado: (2022)

Hepatic changes by benznidazole in a specific treatment for Chagas disease
por: Pavan, Tycha Bianca Sabaini, et al.
Publicado: (2018)

Access to benznidazole for Chagas disease in the United States—Cautious optimism?
por: Alpern, Jonathan D., et al.
Publicado: (2017)

Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
por: Vázquez, Cristina, et al.
Publicado: (2023)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
por: Zrein, Maan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cqsf72dqqe5n3ellshhnueqhkp